This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Alessandro Magli: Innovator in Myogenic Progenitor Cell Isolation
Introduction
Alessandro Magli is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of cellular biology, particularly in the isolation of myogenic progenitor cells. His work is essential for advancing research in muscle regeneration and related therapies.
Latest Patents
Alessandro Magli holds a patent titled "Method of isolating myogenic progenitors using CD54." This patent provides methods to isolate myogenic progenitor cells and outlines their potential applications. The innovation is crucial for researchers looking to harness these cells for therapeutic purposes.
Career Highlights
Alessandro Magli is affiliated with the Regents of the University of Minnesota. His role at this prestigious institution allows him to engage in cutting-edge research and collaborate with other experts in the field. His dedication to advancing scientific knowledge is evident in his innovative work.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Alessandro Magli's contributions to the field of myogenic progenitor cell isolation highlight his role as an important inventor in biomedical research. His patent and ongoing work continue to influence advancements in muscle regeneration therapies.